BioGeneration Ventures Fund III closed at...Dutch venture capital company BioGeneration Ventures (BGV) has closed its third fund, BGV III, at €82m exceeding the original target by €32m. more ➔
Ablynx IPO Ablynx raises US$230mBelgian nanobody producer Ablynx closes an initial public offering of American Depositary Shares at Nasdaq totalling US$200m plus a fully exercised greenshoe option amounting aggregate gross … more ➔
CPHI, CPHI Worldwide, pharma professionals CPHI Worldwide expands outreach The worlds largest event for pharma professionals, CPHI worldwide, will see an expansion to the rapidly-growing field of biologics next year in Madrid more ➔
Biotech Ireland, Limerick County, Regeneron Pharmaceuticals 300 jobs more: US company expands its Iris... US biotech company Regeneron Pharmaceuticals revealed plans to create some 300 new jobs in Ireland’s Limerick County. The jobs form part of a US$100m (€85m) expansion plan for the company’s campus … more ➔
Bill & Melinda Gates Foundation, Immunethep, portuegese biotech Immunethep receives grant from Gates Found... Portuguese biotech company Immunethep has convinced the Bill & Melinda Gates Foundation to hand out a grant to test its antibody against the bacterial extracellular virulence factor GAPDH. more ➔
cd46 protein, multiple sclerosis EU researchers unveil how T cell dysfuncti...French and British scientists have revealed insight into how a critical immune regulatory pathway contributes to the development of multiple sclerosis (MS), potentially paving the way toward future immunotherapies … more ➔
Uniqure readies share stock offering Dutch Uniqure BV launched a public offering of five million shares of common stock. Underwriters over-allotment will be an additional 750,000 shares. more ➔
bioethanol, biofuel Biofuels: study challenges EUs tank or...A comprehensive sustainability assessment carried out by Cologne-based nova-Institute shows that first and second-generation bioethanol is feasible for the EUs climate strategy. The study challenges … more ➔
ADC Therapeutics raises US$200m in private... Swiss cancer antibody-drug conjugate (ADC) developer ADC Therapeutics Sarl (Epalinges) has raised US$200m million through an oversubscribed private placement. Investors include Auven Therapeutics, … more ➔
bioeconomy, EuropaBio, European Biotech week Valuating biotechs benefitsEuropean Biotech Week:?Highlighting the benefits biotechnology has brought to pharma development, agriculture and – last but not least – the bioeconomy, industry association EuropaBio celebrated … more ➔
